Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients
Aims Mitogen-activated protein kinase (MAPK) pathway alteration is a major oncogenic driver in paediatric low-grade gliomas (LGG) and some adult gliomas, encompassing BRAF (most common) and non-BRAF alterations. The aim was to determine the frequency, molecular spectrum and clinicopathological featu...
محفوظ في:
| المؤلف الرئيسي: | Ahmed, Amir A. (author) |
|---|---|
| مؤلفون آخرون: | Alateeqi, Mona (author), Ali, Nawal Y. (author), Ali, Rola H. (author), Almanabri, Mohamad (author), Almarzooq, Ammar (author), Almurshed, Maryam (author), Alqallaf, Zainab (author), Alsaber, Ahmad (author), Bahzad, Shakir (author), Benobaid, Noelle (author), Hussein, Rania (author), Jama, Hiba (author), Khalifa, Nisreen M. (author), Mohammed, Eiman M.A. (author) |
| منشور في: |
2024
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/11675/12179 http://www.scopus.com/inward/record.url?scp=85183662845&partnerID=8YFLogxK |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients
حسب: Ahmed, Amir A.
منشور في: (2024) -
Sensitive determination of BRAF copy number in clinical samples by pyrosequencing
حسب: El Maarri, Osman
منشور في: (2011) -
Prognostic impact of adenylyl cyclase-associated protein 2 (CAP2) in glioma: A clinicopathological study
حسب: Zahraa Saker (18974026)
منشور في: (2020) -
Identification of novel natural drug candidates against BRAF mutated carcinoma; An integrative in-silico structure-based pharmacophore modeling and virtual screening process
حسب: F. A. Dain Md Opo (18418845)
منشور في: (2022) -
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin
حسب: Abi-Habib, Ralph J.
منشور في: (2005)